Upper gastrointestinal bleeding risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Upper gastrointestinal bleeding}} | {{Upper gastrointestinal bleeding}} | ||
{{CMG}}; {{AE}} {{AKK}} ; {{ADG}} | |||
==Overview== | |||
Common risk factors in the development of upper gastrointestinal bleeding include advancing age, previous history of gastrointestinal bleed, [[chronic kidney disease]], underlying [[cardiovascular disease]], [[cirrhosis]] and [[portal hypertension]], presence of [[H.pylori peptic ulcer disease pathophysiology|H.pylori infection]], [[NSAIDs|NSAID's]] or [[aspirin]] use in patients with a history of [[Peptic ulcer disease|ulcer disease]], patients on [[dual antiplatelet therapy]] and patients of 60 years or older. | |||
==Risk Factors== | |||
Common risk factors in the development of upper gastrointestinal bleeding include: | |||
*Advancing age<ref name="pmid21341933">{{cite journal |vauthors=Morales Uribe CH, Sierra Sierra S, Hernández Hernández AM, Arango Durango AF, López GA |title=Upper gastrointestinal bleeding: risk factors for mortality in two urban centres in Latin America |journal=Rev Esp Enferm Dig |volume=103 |issue=1 |pages=20–4 |year=2011 |pmid=21341933 |doi= |url=}}</ref><ref name="pmid19744387">{{cite journal |vauthors=Rodríguez-Hernández H, Rodríguez-Morán M, González JL, Jáquez-Quintana JO, Rodríguez-Acosta ED, Sosa-Tinoco E, Guerrero-Romero F |title=[Risk factors associated with upper gastrointestinal bleeding and with mortality] |language=Spanish; Castilian |journal=Rev Med Inst Mex Seguro Soc |volume=47 |issue=2 |pages=179–84 |year=2009 |pmid=19744387 |doi= |url=}}</ref><ref name="pmid24108375">{{cite journal |vauthors=Corzo Maldonado MA, Guzmán Rojas P, Bravo Paredes EA, Gallegos López RC, Huerta Mercado-Tenorio J, Surco Ochoa Y, Prochazka Zárate R, Piscoya Rivera A, Pinto Valdivia J, De los Ríos Senmache R |title=[Risk factors associated to mortality by upper GI bleeding in patients from a public hospital. A case control study] |language=Spanish; Castilian |journal=Rev Gastroenterol Peru |volume=33 |issue=3 |pages=223–9 |year=2013 |pmid=24108375 |doi= |url=}}</ref><ref name="pmid5192276">{{cite journal |vauthors=Soldatov IB, Tokman AS, Esipovich IaN |title=[On the forms of dissemination of advanced experience of otorhinolaryngologists in dispensary work] |language=Russian |journal=Zdravookhr Ross Fed |volume=11 |issue=4 |pages=19–21 |year=1967 |pmid=5192276 |doi= |url=}}</ref> | |||
*Previous history of gastrointestinal bleed | |||
*[[Chronic kidney disease]] | |||
*Underlying [[cardiovascular disease]] | |||
*[[Cirrhosis]] and [[portal hypertension]] | |||
*Presence of [[H.pylori peptic ulcer disease pathophysiology|H.pylori infection]] | |||
*[[NSAIDs|NSAID's]] or [[aspirin]] use in patients with a history of [[Peptic ulcer disease|ulcer disease]] | |||
*Patients on [[dual antiplatelet therapy]] | |||
*Age 60 years or older | |||
*Patients taking [[glucocorticoids]] | |||
*[[Dyspepsia]] | |||
*[[Gastroesophageal reflux disease]] | |||
*Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and [[coagulopathy]]. | |||
*Rare conditions associated with gastric acid hypersecretion, such as [[Zollinger-Ellison syndrome]], [[mastocytosis]], or a retained antrum following partial [[gastrectomy]]. | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
| Line 12: | Line 30: | ||
[[Category:Medical emergencies]] | [[Category:Medical emergencies]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 18:05, 29 November 2017
|
Upper gastrointestinal bleeding Microchapters |
|
Differentiating Upper Gastrointestinal Bleeding from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Management |
|
Surgery |
|
Case Studies |
|
Upper gastrointestinal bleeding risk factors On the Web |
|
American Roentgen Ray Society Images of Upper gastrointestinal bleeding risk factors |
|
Directions to Hospitals Treating Upper gastrointestinal bleeding |
|
Risk calculators and risk factors for Upper gastrointestinal bleeding risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arzu Kalayci, M.D. [2] ; Aditya Ganti M.B.B.S. [3]
Overview
Common risk factors in the development of upper gastrointestinal bleeding include advancing age, previous history of gastrointestinal bleed, chronic kidney disease, underlying cardiovascular disease, cirrhosis and portal hypertension, presence of H.pylori infection, NSAID's or aspirin use in patients with a history of ulcer disease, patients on dual antiplatelet therapy and patients of 60 years or older.
Risk Factors
Common risk factors in the development of upper gastrointestinal bleeding include:
- Advancing age[1][2][3][4]
- Previous history of gastrointestinal bleed
- Chronic kidney disease
- Underlying cardiovascular disease
- Cirrhosis and portal hypertension
- Presence of H.pylori infection
- NSAID's or aspirin use in patients with a history of ulcer disease
- Patients on dual antiplatelet therapy
- Age 60 years or older
- Patients taking glucocorticoids
- Dyspepsia
- Gastroesophageal reflux disease
- Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and coagulopathy.
- Rare conditions associated with gastric acid hypersecretion, such as Zollinger-Ellison syndrome, mastocytosis, or a retained antrum following partial gastrectomy.
References
- ↑ Morales Uribe CH, Sierra Sierra S, Hernández Hernández AM, Arango Durango AF, López GA (2011). "Upper gastrointestinal bleeding: risk factors for mortality in two urban centres in Latin America". Rev Esp Enferm Dig. 103 (1): 20–4. PMID 21341933.
- ↑ Rodríguez-Hernández H, Rodríguez-Morán M, González JL, Jáquez-Quintana JO, Rodríguez-Acosta ED, Sosa-Tinoco E, Guerrero-Romero F (2009). "[Risk factors associated with upper gastrointestinal bleeding and with mortality]". Rev Med Inst Mex Seguro Soc (in Spanish; Castilian). 47 (2): 179–84. PMID 19744387.
- ↑ Corzo Maldonado MA, Guzmán Rojas P, Bravo Paredes EA, Gallegos López RC, Huerta Mercado-Tenorio J, Surco Ochoa Y, Prochazka Zárate R, Piscoya Rivera A, Pinto Valdivia J, De los Ríos Senmache R (2013). "[Risk factors associated to mortality by upper GI bleeding in patients from a public hospital. A case control study]". Rev Gastroenterol Peru (in Spanish; Castilian). 33 (3): 223–9. PMID 24108375.
- ↑ Soldatov IB, Tokman AS, Esipovich I (1967). "[On the forms of dissemination of advanced experience of otorhinolaryngologists in dispensary work]". Zdravookhr Ross Fed (in Russian). 11 (4): 19–21. PMID 5192276. Vancouver style error: initials (help)